National Center for Research Resources; Notice of Closed Meeting, 21698 [E9-10804]
Download as PDF
<![CDATA[
21698
Federal Register / Vol. 74, No. 88 / Friday, May 8, 2009 / Notices
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before May 22, 2009. Time allotted
for each presentation may be limited. If
the number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by May 26, 2009.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Nicole
Vesely at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/oc/advisory/
default.htm for procedures on public
conduct during advisory committee
meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: April 30, 2009.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9–10729 Filed 5–7–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
hsrobinson on PROD1PC76 with NOTICES
National Center for Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
VerDate Nov<24>2008
17:51 May 07, 2009
Jkt 217001
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
BioTechnology 2 SEP.
Date: June 25, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Lee Warren Slice, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources, 6701
Democracy Blvd. Room 1068, Bethesda, MD
20892, 301–435–0965.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333; 93.702, ARRA Related
Construction Awards., National Institutes of
Health, HHS).
Dated: May 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–10804 Filed 5–7–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
NIH–Sponsored Workshop: ‘‘Soy
Protein and Isoflavones Research:
Challenges in Designing and
Evaluating Intervention Studies’’;
Notice
The National Institutes of Health
(NIH) Office of Dietary Supplements
(ODS) is co-sponsoring a workshop
entitled ‘‘Soy Protein and Isoflavones
Research: Challenges in Designing and
Evaluating Intervention Studies’’ with
other NIH Institutes and Centers
(National Center for Complementary
and Alternative Medicine, National
Cancer Institute, National Institute of
Arthritis and Musculoskeletal and Skin
Diseases, National Institute on Aging,
and the Division of Nutrition Research
Coordination). The workshop will be
held on July 28–29 at the Bethesda
North Marriott Hotel and Conference
Center, Bethesda, Maryland.
Summary
NIH has been supporting research on
soy in its many forms for a range of
outcomes. Questions concerning which
forms of soy might be better for studies
of specific health outcomes and at what
doses led the National Center for
Complementary and Alternative
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Medicine and the Office of Dietary
Supplements to commission an
evidence-based review of the literature.
The resulting report (https://
www.ahrq.gov/clinic/tp/soytp.htm)
found a large, but weak, literature with
equivocal findings. Moreover, the
National Institute of Environmental
Health Sciences provided some
troubling data about soy products used
in research, which included
confounding produced by unanticipated
levels of phytoestrogens in animal feed
(Heindel et al. Environmental Health
Perspectives 2008:116(3);389–393).
Hence, components of the NIH became
concerned about the quality of data from
human studies.
The purpose of this workshop,
therefore, is to provide guidance for the
next generation of soy protein and
isoflavone human research. Specifically,
the workshop objectives are to identify
(1) methodological issues relative to
exposures and interventions that may
confound study results and
interpretation and (2) scientifically
sound and useful options and solutions
for dealing with these issues in the
design, conduct, reporting of results,
and interpretation of ongoing and future
studies. NIH is seeking input from
scientists from multiple disciplines,
including nutritionists, physicians,
analytical chemists, epidemiologists,
biochemists, and clinical trialists from
academia, industry, and government.
This highly participatory workshop will
address issues related to population
exposure to soy and other
phytoestrogens, factors influencing
variability of response to soy
interventions and negative
consequences of exposure, methods and
tools to assess exposure, product
composition, and analytic methods to
assess soy product constituents and
metabolites.
Registration
Seating at this workshop is very
limited. To register, please e-mail by
June 1, 2009, your name, complete
contact information (including phone
number, e-mail address, and street
address), and the dates that you plan to
attend to Ms. Tricia Wallich at
wallich@csionweb.com . If you do not
have access to e-mail, please call Ms.
Wallich at 301–670–0270 (not a toll-free
number). Ms. Wallich will be
coordinating the registration for this
workshop.
Dated: May 4, 2009.
Raynard S. Kington,
Acting Director, National Institutes of Health.
[FR Doc. E9–10788 Filed 5–7–09; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\08MYN1.SGM
08MYN1
]]>Agencies
[Federal Register Volume 74, Number 88 (Friday, May 8, 2009)]
[Notices]
[Page 21698]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-10804]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Research Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Research Resources
Special Emphasis Panel; BioTechnology 2 SEP.
Date: June 25, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Lee Warren Slice, PhD, Scientific Review
Officer, Office of Review, National Center for Research Resources,
6701 Democracy Blvd. Room 1068, Bethesda, MD 20892, 301-435-0965.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure, 93.306, 93.333; 93.702,
ARRA Related Construction Awards., National Institutes of Health,
HHS).
Dated: May 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-10804 Filed 5-7-09; 8:45 am]
BILLING CODE 4140-01-P
